Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-03-20 | George L. Fotiades - Mr. Fotiades has been Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC since 2007. The Board concluded that Mr. Fotiades should continue to serve as a director due to his senior executive experience and board level experience with global organizations. Committee membership: Corporate Governance. Director compensation: $150,000. |
| 2013-03-26 | George L. Fotiades 59 2011 Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC YES Audit Committee member Director compensation table shows total $220,105. |
| 2014-03-25 | Mr. Fotiades has been Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC (private equity investing) since 2007. Mr. Fotiades served as Chairman of Catalent Pharma Solutions (formerly part of Cardinal Health, Inc.) from 2007 until 2010. He is a member of the board of directors of the following companies: Prologis (integrated distribution facilities and services) and Cantel Medical (infection prevention and control products). He was a director of Alberto-Culver (personal care and beauty products) from 2006 until the closing of the acquisition of Alberto Culver by Unilever PLC in 2011. He also represents Diamond Castle on the boards of several privately held companies. The Board of Directors concluded that Mr. Fotiades should serve as a director of AptarGroup in part due to his experience from previously held senior executive positions at leading healthcare and consumer product companies including Cardinal Health, Inc., Catalent Pharma Solutions, the former Warner-Lambert's Consumer Health Products Group (now part of Johnson & Johnson) and Bristol-Myers Squibb's Consumer Products, Japan division. The Board also considered his present and past board level experience with global organizations. Board Compensation section: G. Fotiades Fees Paid in Cash $87,000, Fair Value of Stock and Option Awards $103,455, Total $190,455. |
| 2015-03-24 | Mr. Fotiades has been Chairman and Operating Partner of Healthcare Investments... Director Compensation table shows total $224,748. |
| 2016-03-22 | Mr. Fotiades has been Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC since 2007. The Board of Directors concluded that Mr. Fotiades should continue to serve as a director of AptarGroup in part due to his experience from previously held senior executive positions at leading healthcare and consumer product companies including Cardinal Health, Inc., Catalent Pharma Solutions, the former Warner-Lambert's Consumer Health Products Group (now part of Johnson & Johnson) and Bristol-Myers Squibb's Consumer Products, Japan division. 2015 DIRECTOR COMPENSATION: Fees Earned or Paid in Cash $100,000; Stock Awards $129,986; Total $229,986. |
| 2017-03-22 | Mr. Fotiades has been Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC (private equity investing) since 2007. He is a member of the board of directors of the following companies: Prologis, Inc. and Cantel Medical Corp. He was a director of Alberto-Culver Co. from 2006 until the closing of the acquisition of Alberto-Culver by Unilever PLC in 2011. The Board of Directors concluded that Mr. Fotiades should continue to serve as a director of Aptar in part due to his experience from previously held senior executive positions at leading healthcare and consumer product companies. The Board also considered his present and past board level experience with global organizations. 2016 DIRECTOR COMPENSATION: Fees Earned or Paid in Cash ($) 100,000; Stock Awards ($) 129,963; Total ($) 229,963. |
| 2019-03-22 | Mr. Fotiades has been Chairman of the Board since 2018. Mr. Fotiades is President and CEO of Cantel Medical Corp. (NYSE-listed manufacturer of infection prevention and control products). He was Operating Partner at Five Arrows Capital Partners (Rothschild Merchant Banking) from April 2017 until March 2019. From 2007 through April 2017, he was Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC (private equity investing). He is a director of the following NYSE-listed companies: Prologis, Inc. (integrated distribution facilities and services) and Cantel Medical Corp. The Board of Directors concluded that Mr. Fotiades should continue to serve as a director of Aptar in part due to his experience from previously held senior executive positions at leading healthcare and consumer product companies including Cardinal Health, Inc., Catalent Pharma Solutions, the former Warner-Lambert's Consumer Health Products Group (now part of Johnson & Johnson) and Bristol-Myers Squibb's Consumer Products, Japan division. The Board also considered his present and past board level experience with global organizations. 2018 DIRECTOR COMPENSATION: G. Fotiades Fees Earned or Paid in Cash ($): 165,000; Stock Awards ($): 150,040; Total ($): 315,040. |
| 2020-03-27 | Mr. Fotiades has been Chairman of the Board since 2018. ... The Chairman of the Board was compensated with $190,000 in cash and $160,000 in equity awards. |
| 2021-03-26 | Mr. Fotiades has been Chairman of the Board since 2018. 2020 Director Compensation: $190,000 fees earned in cash, $160,000 stock awards, total $350,000. |
| 2022-03-25 | GEORGE L. FOTIADES Age: 68 Director since: 2011 Committees: Corporate Governance (Chair) 2021 Director Compensation G. Fotiades 205,000 Fees Earned or Paid in Cash, 170,000 Stock Awards, Total 377,000 |
| 2023-03-24 | Mr. Fotiades has been Chairman of the Board since 2018. Mr. Fotiades was the President and CEO of Cantel Medical Corp. ... The Chairman, who is not an executive of Aptar, received an annual retainer of $205,000. ... On May 4, 2022, the Chairman of the Board was granted 1,475 RSUs with a grant date fair value of approximately $170,000. Total compensation $375,000. |
| 2024-03-22 | Mr. Fotiades was the Chairman of the Board of Aptar from May 2018 to May 2023. He has served as Executive Chairman of Elio Health, a private investment firm, since he co-founded the firm in 2022. Mr. Fotiades was the President and CEO of Cantel Medical Corp. (a NYSE-listed manufacturer of infection prevention and control products) from March 2019 until its acquisition by STERIS plc in June 2021. Mr. Fotiades was an Operating Partner in the healthcare practice of Five Arrows Capital Partners (Rothschild Merchant Banking) from April 2017 to March 2019. From 2007 to April 2017, he was a partner of Healthcare Investments at Diamond Castle Holdings LLC (private equity investing). Mr. Fotiades was chairman of Catalent Pharma Solutions, Inc., a provider of advanced technologies for pharmaceutical, biotechnology and consumer health companies, from June 2007 to February 2010. He is currently a director of Prologis, Inc. (a NYSE-listed integrated distribution facilities and services) and previously was a director of Cantel Medical Corp. Committees: Audit. 2023 Director Compensation: $260,958. |
| 2025-03-28 | GEORGE L. FOTIADES Age: 71 Independent Director since: 2011 Committees: Audit ... G. Fotiades 111,000 160,072 0 271,072 |
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-23 | Mr. Fotiades, 64, has been an operating partner at Five Arrows Capital Partners since April 2017. He serves as Chair of the Compensation Committee. His total director compensation for 2017 was $312,458. |
| 2019-03-22 | George L. Fotiades 65, Director since June 2011 (prior to the Merger served as a trustee of the Trust from December 2001 to June 2011) Mr. Fotiades, 65, was appointed President and Chief Executive Officer of Cantel Medical Corp., a provider of infection prevention and control products, in March 2019. Board Committees: Compensation (Chair) Other public directorships: AptarGroup, Inc. and Cantel Medical Corp. |
| 2020-03-20 | George L. Fotiades 66, was appointed President and Chief Executive Officer of Cantel Medical Corp. Board Committees: Compensation (Chair). Director Compensation for Fiscal Year 2019 shows total compensation of $347,465. |
| 2021-03-19 | George L. Fotiades · Director since June 2011 (prior to the Merger served as a trustee of the Trust from December 2001 to June 2011) · Board Committees: Compensation (Chair) · Other public directorships: AptarGroup, Inc. and Cantel Medical Corp.* Mr. Fotiades, 67, was appointed President and Chief Executive Officer* of Cantel Medical Corp., a provider of infection prevention and control products, in March 2019. |
| 2022-03-25 | Mr. Fotiades, 68, served as President and Chief Executive Officer of Cantel Medical Corp. ... Board Committees: Compensation (Chair). ... Director Compensation for Fiscal Year 2021 shows total compensation of $346,985. |
| 2023-03-24 | Mr. Fotiades, 69, served as president and chief executive officer of Cantel Medical Corp. He is chairman of the board of AptarGroup, Inc. Mr. Fotiades serves as Chair of the Compensation Committee. Mr. Fotiades’ total compensation for 2022 was $381,918. |
| 2024-03-29 | Mr. Fotiades, 70, served as president and chief executive officer of Cantel Medical Corp. Director since June 2011. Board committees: Compensation (chair). 2023 total compensation $382,409. |
| 2025-03-28 | Mr. Fotiades, 71, served as president and CEO of Cantel Medical Corp. Director since June 2011. Board committees: Compensation (chair). Director compensation for 2024 includes cash and stock awards totaling $384,952. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22